Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A rational basis for selection among drugs of the same class.

× No keyword cloud information.

21 in total

1. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.

Authors: L Mazzolai; M Maillard; J Rossat; J Nussberger; H R Brunner; M Burnier
Journal: Hypertension Date: 1999-03 Impact factor: 10.190

Review 2. Matching the right drug to the right patient in essential hypertension.

Authors: M J Brown
Journal: Heart Date: 2001-07 Impact factor: 5.994

3. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors: E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal: N Engl J Med Date: 2001-09-20 Impact factor: 91.245

4. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

Authors: G G Schwartz; A G Olsson; M D Ezekowitz; P Ganz; M F Oliver; D Waters; A Zeiher; B R Chaitman; S Leslie; T Stern
Journal: JAMA Date: 2001-04-04 Impact factor: 56.272

5. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors: S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal: N Engl J Med Date: 2000-01-20 Impact factor: 91.245

6. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

Authors: P Svensson; U de Faire; P Sleight; S Yusuf; J Ostergren
Journal: Hypertension Date: 2001-12-01 Impact factor: 10.190

7. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors: B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal: N Engl J Med Date: 2001-09-20 Impact factor: 91.245

8. Effect of carvedilol on survival in severe chronic heart failure.

Authors: M Packer; A J Coats; M B Fowler; H A Katus; H Krum; P Mohacsi; J L Rouleau; M Tendera; A Castaigne; E B Roecker; M K Schultz; D L DeMets
Journal: N Engl J Med Date: 2001-05-31 Impact factor: 91.245

9. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors: Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal: Lancet Date: 2002-03-23 Impact factor: 79.321

10. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

Authors:
Journal: Lancet Date: 2001-09-29 Impact factor: 79.321

4 in total

4. Maternal ethnicity and its impact on the haemodynamic and blood pressure response to labetalol for the treatment of antenatal hypertension.

Authors: D Stott; M Bolten; D Paraschiv; I Papastefanou; J B Chambers; N A Kametas
Journal: Open Heart Date: 2016-03-22